Explore Long Term Risks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Explore Long Term Risks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Explore Long Term Risks Today - Breaking & Trending Today

People Who Stopped Taking the Weight Loss Drug Tirzepatide Regained Nearly Half the Weight They Lost

Published: December 12, 2023

A new study of tirzepatide, the main ingredient in Mounjaro and Zepbound, finds that weight loss gains are hard to maintain after treatment ends.

Source: everydayhealth.com

Related Topics:

United StatesNew YorkLouis AronneFatima Cody StanfordEndocrine SocietyDrug AdministrationHenry Ford Health In DetroitHarvard Medical SchoolMetabolic Clinical Research At Weill Cornell MedicineEveryday HealthMore Research Is Needed To Explore LongWeight Cycling Can Harm HealthWeight ManagementMetabolic Clinical ResearchWeill Cornell MedicineMassachusetts General HospitalWho Stopped Taking Zepbound Were StillAverage AfterObesity Can Also Improve HypertensionHeart DiseaseThey Will Gradually Regain LostCycling Can Harm HealthResearch Is NeededExplore Long Term RisksSuki Singh